December 4, 2025 | 12:00pm-12:30pm ET
Innovations in biosimilars: what health systems professionals should anticipate for 2026
Archive
Past webinar topics
AMCP PIE Webinar: Beta Cell Preservation and Disease-Modifying Treatment for Autoimmune Type 1 Diabetes: Pre-Approval Information Exchange | Oct 21, 2025
AMCP PIE Webinar: A Clinical Overview of Investigational Menin Inhibitor for the Treatment of NPM1-mutated R/R acute myeloid leukemia | Aug 28, 2025
Cencora | NASP Webinar: Breaking the Mold: What’s Next for Biosimilars and How to Stay Ahead | Aug 21, 2025
AMCP PIE Webinar: UGN-102 Pre-Approval Information Exchange (PIE) Presentationa | March 26, 2025
Cencora | NASP Webinar: Enhancing Specialty Drug Review and Formulary Insights | March 25, 2025
AMCP PIE Webinar: Investigational Cell-Based Autologous Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)a | March 4, 2025
AMCP PIE Webinar: Overview of clinical data for a potential treatment for PTSD in adults | December 5, 2024
AMCP PIE Webianr: Delgocitinib for the treatment of Chronic Hand Eczema (CHE) | November 20, 2024
AMCP PIE Webinar: Vutrisiran Preapproval Information Exchange Webinar | October 30, 2024
PIE webinars are sponsored. The content of the webinars and opinions expressed by the presenters and those of the sponsor or presenters and not of AMCP or FormularyDecisions. FormularyDecisions is proud to partner with AMCP to enable information sharing between healthcare decision-makers and biopharma companies. At the time of the webinar, the product was in the clinical evaluation stage and had not been approved for use by the FDA. The safety and efficacy had not been established.
